Skip to main content

Contact

Home
About
News
Publications
Contact

Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis

Science

16 May 2025

Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis

This article is hosted externally.

SHARE ARTICLE

Qureight offers a developed technology software for AI related data analysis for use in clinical trials that is certified to ISO13485 & ISO27001, validated software application for regulated industries like medical devices and high-tech products. All data held is within the legislation of GDPR, HIPAA, 21 CFR Part 11 and registered on the NHS Digital Toolkit.

Redefining precision medicine

Qureight Ltd
50 - 60 Station Road
Cambridge
CB1 2JH
United Kingdom
Company reg #11132399
VAT #352 3102 45

Home
About
News
Publications
Contact
Trust Centre

Copyright © 2025 Qureight